跳至主要内容
临床试验/NCT03276481
NCT03276481已完成不适用

Prospective Evaluation of Gustatory Function (Taste) In Patients Undergoing Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2017年8月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
1
主要终点
Feasibility of comprehensive chemical gustometry in participants with multiple myeloma undergoing autologous HCT

研究概览

简要总结

The purpose of this study is to study taste disturbances on patients with myeloma who received high dose melphalan.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 21 or above with diagnosis of multiple myeloma (myeloma is almost unheard of in patients less than 21 years of age).
  • Scheduled to receive conditioning chemotherapy with melphalan followed by upfront or salvage autologous peripheral blood hematopoietic stem cell transplantation
  • English or Spanish speaking
  • Calculated creatinine clearance > 40 mL/min

排除标准

  • Prior head and neck radiation.
  • Severe periodontal infection. Poor oral hygiene and dentition as determined by pre HCT dental assessment.
  • Pregnancy
  • Patients with pre-existing moderate-severe dysgeusia

结局指标

主要结局

Feasibility of comprehensive chemical gustometry in participants with multiple myeloma undergoing autologous HCT

时间窗: Change from baseline assessment up to 100 days

The primary objective of this protocol is to evaluate the feasibility of comprehensive chemical gustometry in participants with MM undergoing autologous HCT. Chemical gustometry will be evaluated at baseline and on days -1, 7, 14, 30 and 100.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验